001     281277
005     20251005002027.0
024 7 _ |a 10.1002/bsa3.70032
|2 doi
024 7 _ |a altmetric:181429655
|2 altmetric
037 _ _ |a DZNE-2025-01092
082 _ _ |a 610
100 1 _ |a Wirth, Miranka
|0 P:(DE-2719)2814122
|b 0
|e First author
245 _ _ |a REMINDer randomized controlled study: Feasibility and impact of an online multimodal mind–body intervention in older adults
260 _ _ |a Hoboken, NJ
|c 2025
|b Wiley
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1759233828_23816
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a Missing Journal: Alzheimer's & Dementia: Behavior & Socioeconomics of Aging (Alzheimer's & Dementia: Behavior & Socioeconomics of Aging) = 2997-3805 (import from CrossRef, Journals: pub.dzne.de)
520 _ _ |a INTRODUCTION: The increasing prevalence of age-related diseases, includingAlzheimer’s disease, underscores the need for accessible, cost-effective lifestyleinterventions to reduce modifiable dementia risk factors and support healthy aging.METHODS: REMINDer is a randomized controlled pilot trial evaluating the feasi-bility and impact of a 6-week online, home-based, live-streamed multimodal groupintervention delivered via videoconferencing. The program, designed for older adults,integrates music, dance movement, and mindfulness. Using a cross-over design (AB-BA), participants (N = 50) are randomized to receive the intervention with two 60-minsessions per week or a passive control (with delayed intervention).RESULTS: Digital outcome assessments were conducted remotely at baseline, post-intervention, and follow-up. Primary outcomes include feasibility (adherence rate)and changes in mental and physical well-being (SF-12). Secondary outcomes includechanges in multi-domain health and lifestyle behaviors.DISCUSSION: REMINDer will provide evidence on the feasibility and preliminary effec-tiveness of a scalable online multimodal intervention to support healthy aging andreduce dementia risk.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: pub.dzne.de
700 1 _ |a Stamer, Selina
|0 P:(DE-2719)9002956
|b 1
700 1 _ |a Podolski, Odile-Sophie
|0 P:(DE-2719)2814781
|b 2
700 1 _ |a Maßalsky, Annemarie
|0 P:(DE-2719)9002946
|b 3
700 1 _ |a Koch, Sabine C.
|b 4
700 1 _ |a Klimecki, Olga
|0 P:(DE-2719)9002456
|b 5
|e Last author
773 _ _ |a 10.1002/bsa3.70032
|g Vol. 1, no. 3, p. e70032
|0 PERI:(DE-600)2201940-6
|n 3
|p e70032
|t Alzheimer's and dementia
|v 1
|y 2025
|x 1552-5260
856 4 _ |u https://pub.dzne.de/record/281277/files/DZNE-2025-01092%20SUP.pdf
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/281277/files/DZNE-2025-01092.pdf
856 4 _ |x pdfa
|u https://pub.dzne.de/record/281277/files/DZNE-2025-01092%20SUP.pdf?subformat=pdfa
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/281277/files/DZNE-2025-01092.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:281277
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2814122
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)9002956
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)2814781
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)9002946
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)9002456
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-06
915 _ _ |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
|0 LIC:(DE-HGF)CCBYNCND4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ALZHEIMERS DEMENT : 2022
|d 2025-01-06
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2025-01-06
|w ger
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-06
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b ALZHEIMERS DEMENT : 2022
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-06
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-06
920 _ _ |l yes
920 1 _ |0 I:(DE-2719)1710011
|k AG Wirth
|l Brain Resilience
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1710011
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21